Minireview: Aromatase and the regulation of estrogen biosynthesis - Some new perspectives

Endocrinology

Volumn 142, Issue 11, 2001, Pages 4589-4594

  Simpson, Evan R ^a   Davis, Susan R ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; ESTROGEN;

BLOOD VESSEL FUNCTION; BONE ATROPHY; BONE MINERALIZATION; CARBOHYDRATE METABOLISM; COGNITION; ENZYME ACTIVITY; EPIPHYSIS; ESTROGEN SYNTHESIS; HUMAN; LIPID METABOLISM; PARACRINE SIGNALING; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPRODUCTION; SHORT SURVEY; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0034749898     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.11.8547     Document Type: Short Survey

References (55)

1. The role of local estrogen biosynthesis in males and females
2. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
3. Effect of testosterone and estradiol in a man with aromatase deficiency
4. Point mutation in the CYP19 gene and its consequence
5. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
6. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
7. Generation and reproductive phenotypes of mice lacking estrogen receptor-β
8. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β
9. Effect of single and compound knockouts of estrogen receptor α (ERα) and β (ERβ) on mouse reproductive phenotypes
10. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene
11. Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene
12. Altered expression of fatty acid metabolizing enzymes in aromatase-deficient mice
13. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
14. Increased adipose tissue in male and female estrogen receptor-α knockout mice
15. Bone has a sexually dimorphic response to aromatase deficiency
16. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene
17. Estradiol acts as a germ cell survivor factor in the human testis in vitro
18. Targeted disruption of the oestrogen receptor gene in male mice causes alteration of spermatogenesis and infertility
19. Morphological analysis of endocytosis in efferent ductules of estrogen receptor-α knockout male mouse
20. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
21. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
22. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis
23. Structural characterization of the human estrogen synthetase (aromatase) gene
24. Structural and functional characterization of human aromatase P450 gene
25. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues
26. Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue
27. Stimulation of aromatase promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-I and chicken ovalbumin upstram promoter transcription factor to the same cisacting element
28. Aromatase expression of human osteoblast-like cells
29. Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary
30. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
31. Aromatase expression in health and disease
32. Phylogenetic distribution of aromatase and other androgen-converting enzymes in the central nervous system
33. Distinct cytochrome P450 aromatase isoforms in zebrafish (D. rerio) brain and ovary are differentially regulated during early development
34. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions
35. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging
36. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology
37. The pathogenesis of gynecomastia
38. Estrogen excess caused by gain-of-function mutations of the CYP19 (aromatase) gene involving the chromosome 15q 21.2-q21.3 region
39. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients
40. Estrogen content and metabolism in human breast tumor tissue and cells
41. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor varozole
42. Aromatase as a therapeutic target in endometriosis
43. Aromatase in bone tissue
44. Aromatase P450 gene expression in human adipose tissue: Role of a Jak/STAT pathway in the regulation of the adipose-specific promoter
45. Tumor necrosis factor-α stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4
46. 2
47. Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy
48. Tissue-specific expression of the human aromatase cytochrome P450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis
49. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells
50. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients
51. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: An epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein β
52. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators
53. Correlation of aromatase and cycloxygenase gene expression in human breast cancer specimens
54. Non-steroidal anti-inflammatory drugs and breast cancer
55. Chemoprevention of breast cancer in rats by celecoxib, a cycloxygenase 2 inhibiton